Te rugăm să aștepți; încărcăm datele diagramei imediat
Comunitate AstraZeneca PLC
About AstraZeneca PLC
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 404,24 lei, with a 24-hour trading volume of 2,26B lei. The asset's market cap is 1,25T lei, after moving -0.03% in the last day.
Tokenized AstraZeneca PLC is trading at 406,28 lei, with a tokenized market cap of 3,04M lei and a 24-hour trading volume of 2,89M lei. The tokenized asset has moved 0.82% in the past 24 hours.